
Center for Community-Engaged Translational Research (CCETR)
Lorna H. McNeill, Ph.D.
Director
- Departments, Labs and Institutes
- Research Centers and Programs
- Center for Community-Engaged Translational Research (CCETR)
The Center for Community-Engaged Translational Research (CCETR), a research resource of the Duncan Family Institute, helps investigators implement their research in community settings and supports the recruitment and retention of minorities and women to clinical trials at MD Anderson. CCETR translates MD Anderson's scientific discoveries into real-world interventions and programs. We offer researchers a range of services from brief initial consultations to develop research questions/ideas to collaborations on grant applications, project implementation and dissemination.
Past Collaborations include:
- Clinical and behavioral research departments across the institution
- MD Anderson Oncology Program at Lyndon B. Johnson (LBJ) Hospital
- Diverse organizations throughout Houston, the region, state and U.S., including minority health organizations, Federally Qualified Health Centers (FQHC), faith-based organizations, cancer survivorship and advocacy organizations and more
Contact Information
Phone: 713-792-6400
Email: ccetr@mdanderson.org
What is community-engaged research?
Community-engaged research is:
- A framework or approach for conducting research with and in the community
- Broad. It includes the full spectrum of approaches that involve the community in the research process. It ranges from research that incorporates only a few elements of community engagement and minimal collaboration to research in which community organizations and researchers are full partners throughout the process.
Our Community Partners
Federally Qualified Health Centers
Health & Cancer Coalitions
Community Services
Survivorship Organizations
Give Now
Your gift will help make a tremendous difference.
Research Areas
Find out about the four types of research taking place at MD Anderson.
Subscribe
Get the latest information on our cancer breakthroughs.